all report title image

CONCUSSION MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Concussion Market, By Assessment Methods (Diagnosis (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scans, Electroencephalography (EEG), X-rays, and Others) and Treatment (Medications)), By End Users (Hospitals, Diagnostic centers, Neurologic clinics, and Research institutions), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

  • Published In : Nov 2024
  • Code : CMI7545
  • Pages :161
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Concussion Market Size and Trends

The global concussion market is estimated to be valued at USD 6.82 Bn in 2024 and is expected to reach USD 10.20 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.

Concussion Market Key Factors

Discover market dynamics shaping the industry: Request sample copy

Advancements in diagnostic technologies coupled with increasing awareness about concussion-related conditions among athletes are expected to drive the market growth. Growing participation in contact sports and rising incidence of head injuries have led to the increased demand for effective concussion management solutions. Moreover, ongoing clinical research for the development of improved neurological assessment and diagnostic tools will further aid the market growth. However, high costs associated with treatment and lack of awareness in developing regions may hinder the global concussion market expansion to some extent during the forecast period.

Concussion Market By Assessment Methods

Discover high revenue pocket segments and roadmap to it: Request sample copy

Insights By Assessment Methods: Diagnosis Dominates Due to Standardized Tests and Protocols

In terms of assessment methods, diagnosis is expected to contribute the highest share with 57.9% in 2024 owing to standardized tests and protocols. When an athlete suffers a head injury, diagnosis allows doctors to properly evaluate the severity and effects using objective measures. This provides consistently reliable information to determine appropriate treatment and clearance for return to play. Sideline assessments immediately after injury utilize tests like the Maddocks questions and Glasgow Coma Scale to check for orientation and mental status.

Insights, By End Users: Hospitals Take Lead Due to Specialized Equipment and Personnel

When treating concussion, hospitals are the leading end user segment, and is expected to hold a market share of 42.1% in 2024 due to their specialized equipment and medical expertise. While mild cases may only require rest at home, more serious injuries demand facilities with round-the-clock care, advanced technology, and multi-disciplinary teams. Hospitals have dedicated neurologic units, imaging machines like magnetic resonance imaging and CT scanners, as well as medical personnel specifically trained in neurology, neurosurgery, and other relevant specialties. Emergency rooms in hospitals are often the first point of access for individuals sustaining concussive blows. 

Regional Insights

Concussion Market Regional Insights

To learn more about this report, Request sample copy

Regional Analysis:

Dominating Region: North America

North America dominates the global market for concussion with a share of 36.2% in 2024. This can be attributed to robust healthcare infrastructure and the presence of favorable reimbursement policies. The region has witnessed significant investments from leading players in technologies such as diagnostic imaging and clinical decision support tools.

Fastest-Growing Region: Asia Pacific

The Asia Pacific market exhibits the fastest growth on account of a large patient pool, rising awareness about concussion diagnosis and management, and increasing healthcare spending. Countries like China and India are emerging as lucrative markets.

Concussion Market Outlook for Key Countries

Technological Adoption and Rising Sports Participation in Canada

Canada held a significant share of the concussion market, driven by the adoption of advanced technologies and increased participation in contact sports such as football, basketball, soccer, and hockey. This surge in sports activity has led to a rise in concussion cases, particularly among high school and college athletes. In the U.S., the Food and Drug Administration (FDA) plays a crucial role by ensuring that products and treatments meet stringent safety and efficacy standards, thereby fostering trust among healthcare providers and patients.

Safety Protocols and Innovation Propel Market Expansion in the U.K.

The concussion market in the U.K. is poised for substantial growth, driven by heightened awareness about concussion risks, especially in sports like football and rugby. Stricter government safety protocols like Care Quality Commission (CQC) Regulations are fostering advancements in diagnosis, treatment, and prevention. Additionally, innovations like portable diagnostic devices and advanced imaging technologies are improving patient outcomes and fueling the demand for cutting-edge solutions.

Strong Healthcare Infrastructure and R&D Boost Market Growth in Germany

The concussion market in Germany is experiencing significant growth, benefiting from a robust healthcare infrastructure supported by numerous hospitals and medical device companies. The government’s Excellence Initiative, which was launched by the German federal and state governments, has bolstered R&D efforts, improved the capabilities of research institutes, and facilitated the development of advanced healthcare solutions.

Rising Awareness and Innovation Propel Growth in India

Government Initiatives coupled with increasing investments in healthcare and sports medicine, position India as a key driver in the expanding global market for concussion. For instance, in September 2024, the All-India Football Federation (AIFF) supports FIFA and World Health Organization’s "Suspect and Protect" campaign to raise awareness about concussion risks in football. The initiative emphasizes recognizing concussion signs and symptoms, which may appear up to 72 hours later, and provides guidance for safe return-to-play protocols. 

Market Concentration and Competitive Landscape

Concussion Market Concentration By Players

Get actionable strategies to beat competition: Request sample copy

Top Strategies Followed by Global Concussion Market Players

  • Established Players: Leading companies in the global concussion market heavily focus on research and development activities to develop innovative products. They invest over 5% of their annual revenue in R&D to stay ahead in the industry. For example, companies like BrainScope and ImPACT Applications are conducting extensive clinical trials to enhance the accuracy of their concussion assessment tools using advanced technologies like artificial intelligence and machine learning.
  • Mid-Level Players: Mid-sized companies in the concussion market aim to provide quality and affordable solutions to address the needs of budget-conscious customers. For instance, Toyobo developed low-cost USB-powered portable electroencephalography (EEG) devices for on-field concussion screening. Other players like Highmark Interactive focus on simplifying existing diagnostic protocols to make concussion evaluations more convenient and pocket-friendly for patients and healthcare facilities.
  • Small-Scale Players: New entrants often target niche consumer segments left untapped by larger competitors. Biodot develops wearable sensors specifically for use in sports like rugby and football where head impacts are frequent. Concussion Analytics provides solutions optimized for pediatric concussion diagnosis and management.

Emerging Startups in the Global Concussion Market

Innovative Technologies: Startups are introducing groundbreaking technologies like BrainScope's portable biomarkers device that measures brain waves and detects subtle changes caused by concussions within minutes of injury. Similarly, Flash Brain Imaging uses specialized cameras to capture functional infrared brain imaging, revealing invisible physiological changes due to concussions. Such innovative solutions have the potential to disrupt traditional assessment methods and diagnostic workflows in the industry.

Sustainable Solutions: Some startups focus on sustainability, like Helmetr which manufactures protective gear from recyclable materials to reduce waste. OpenWater produces affordable hydrogel sensors that are biodegradable, enabling single-use concussion screening without generating long-term e-waste.

Concussion Industry News

  • In September 2024, Nihon Kohden, a global leader in medical device innovation, announced that its Board of Directors approved the acquisition of a 71.4% stake in NeuroAdvanced Corp. (NAC), the parent company of Ad-Tech Medical Instrument Corporation in the U.S. This strategic move will make both NAC and Ad-Tech consolidated subsidiaries of Nihon Kohden, as their respective capital will account for 10% or more of Nihon Kohden’s total capital.
  • In July 2024, Oculogica, a neuro-diagnostic company specializing in eye-tracking technology, announced that Health Canada approved its EyeBOX concussion diagnostic device. This approval allows healthcare professionals across Canada to utilize EyeBOX for swift and accurate assessment of mild traumatic brain injuries (mTBIs).
  • In April 2024, Abbott, a global healthcare company, received the U.S. Food and Drug Administration (FDA) clearance for its i-STAT TBI cartridge for use with whole blood. This advancement enables doctors to evaluate patients with suspected concussions at the bedside, delivering lab-quality results in just 15 minutes. Previously, TBI assessment tests required plasma or serum samples to be sent to a laboratory for processing and analysis.
  • In December 2023, Integra LifeSciences Holdings Corporation, a leading global provider of regenerative technologies and neurosurgical solutions, finalized a definitive agreement to acquire Acclarent, Inc. from Ethicon, Inc., a subsidiary of Johnson & Johnson MedTech, for USD 275 million in cash at closing, with customary purchase price adjustments. Additionally, there is a provision for an extra USD 5 million contingent upon meeting certain regulatory milestones.

Key Takeaways from Analyst

The global concussion market is poised for significant growth, driven by the rising incidence of concussions in sports and other physical activities. Increased participation in contact sports and heightened awareness about concussion diagnosis and management are key factors propelling this expansion. However, the high costs associated with concussion treatment may pose challenges to rapid market growth.

North America currently leads the global concussion market, a position expected to continue due to substantial investments in sports medicine and safety equipment in the U.S. the Asia Pacific region is anticipated to experience the fastest growth, fueled by a growing emphasis on sports and fitness in emerging economies like China and India.

Technological advancements in concussion diagnostic tools present lucrative opportunities for market players. The development of advanced biomechanical sensors enables immediate on-field concussion detection, facilitating prompt treatment. Additionally, collaborations between sports federations and medical technology firms are positive steps toward reducing long-term brain injury risks associated with sports-related concussions.

Market Report Scope

Concussion Market Report Coverage

Report Coverage Details
Base Year: 2023 Market Size in 2024: US$ 6.82 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 5.9% 2031 Value Projection: US$ 10.20 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Assessment Methods: Diagnosis (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scans, Electroencephalography (EEG), X-rays, and Others) and Treatment (Medications)
  • By End Users: Hospitals, Diagnostic centers, Neurologic clinics, and Research institutions
Companies covered:

Nihon Kohden Corporation, Integra LifeSciences, Compumedics Limited, BioDirection (NanoDx), Oculogica, Abbott Laboratories, BrainScope Company Inc., Magstim, BIOMÉRIEUX S.A., Advanced Brain Monitoring, Inc., Healius Limited, Siemens Healthineers, GE Healthcare, Philips Healthcare, and Medtronic plc

Growth Drivers:
  • Increasing awareness about concussion management in sports and healthcare sectors
  • Rising incidence of sports-related injuries leading to higher diagnosis rates
Restraints & Challenges:
  • Limited availability of advanced diagnostic tools in developing regions
  • High costs associated with concussion treatment and rehabilitation

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Market Dynamics

Market Driver - Increasing awareness about concussion management in sports and healthcare sectors

With concussions coming to the forefront in recent years due to lawsuits and media coverage of the long-term impact of repetitive brain injuries in contact sports like American football, ice hockey, and soccer, awareness about proper concussion management has grown considerably in both sporting and healthcare sectors. For instance, in July 2024, an article from the American Academy of Neurology, annually in the U.S., between 1.6 and 3.8 million sports-related concussions occur. Sports such as basketball, football, baseball, volleyball, and wrestling are commonly associated with these injuries. Moreover, according to data from Engage First Aid released in February 2024, National Football League (NFL) players have a 28% chance of experiencing a concussion during their careers.

Market Challenge - Limited availability of advanced diagnostic tools in developing regions

One of the key challenges currently seen in the global concussion market is the limited availability of advanced diagnostic tools in developing regions. Concussions can be difficult to diagnose, especially in the early stages, and require neurological assessments as well as imaging tools like CT scans and MRIs to rule out serious injuries like hematomas or skull fractures. However, in many developing parts of the world like South Asia and Latin America, the healthcare infrastructure and availability of high-end technology is still lacking.

Market Opportunity - Growth in telemedicine and remote monitoring solutions for concussion management

One of the major opportunities seen for the global concussion market is in the growing space of telemedicine and remote patient monitoring solutions. With advancements in digital health technologies, there is a push towards developing virtual care models for managing various health conditions, including mild traumatic brain injuries like concussions. Telemedicine platforms, online cognitive assessments, and wireless home-monitoring devices enhance access to concussion care beyond traditional healthcare settings.

Key Stakeholders of Market

What does Growth in the Concussion Market mean for Different Stakeholders?

The concussion industry has multiple players with varied designations and offers multiple opportunities based on their scope of operations.

Key Clinical Diagnostics Stakeholder

Opportunities Due to Concussion Industry Growth

Diagnostic Equipment Manufacturers

Expansion of markets for advanced diagnostic instruments, including PCR machines, immunoassay analyzers, and next-generation sequencing systems.

Clinical Laboratories

Growth in demand for comprehensive diagnostic services, including molecular testing, genetic screening, and personalized health assessments.

Point-of-Care Testing Providers

Opportunities to develop and distribute rapid diagnostic tests, expanding access to quick and accurate medical diagnostics in various settings.

Healthcare Providers

Enhanced ability to offer personalized medicine and early disease detection, improving patient outcomes and expanding clinical services.

Healthcare IT Firms

Expanding into diagnostic data management, laboratory information systems (LIS), and integration of diagnostic data with electronic health records.

Medical Device Companies

Collaborating with diagnostic firms to develop integrated diagnostic devices and expanding into new areas such as wearable diagnostics.

Pharmaceutical Companies

Leveraging diagnostic tools for drug development and personalized medicine, enhancing drug efficacy and patient stratification in clinical trials.

Biotech Firms

Developing and commercializing biomarkers and companion diagnostics, supporting personalized treatment plans and targeted therapies.

Diagnostic Equipment Manufacturers

Expansion of markets for advanced diagnostic instruments, including PCR machines, immunoassay analyzers, and next-generation sequencing systems.

Clinical Laboratories

Growth in demand for comprehensive diagnostic services, including molecular testing, genetic screening, and personalized health assessments.

Venture Capitalists in Diagnostics

Investment opportunities in startups developing innovative diagnostic technologies, including AI-driven diagnostics and home testing solutions.

Private Equity Investors

Potential to invest in diagnostic companies with cutting-edge technologies and scalable business models, driving industry consolidation.

Diagnostic Consultants

Providing expertise in regulatory compliance, market access, and the commercialization of new diagnostic products and services.

Retail Pharmacies

Offering diagnostic services and home testing kits, expanding customer care services and increasing market reach.

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Market Segmentation

  •  Assessment Methods Insights (Revenue, USD Bn, 2019 - 2031)
    • Diagnosis
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT) scans
    • Electroencephalography (EEG)
    • X-rays
    • Others
    • Treatment
    • Medications
    • Rehabilitation therapies
    • Surgical interventions
  •  End Users Insights (Revenue, USD Bn, 2019 - 2031)
    • Hospitals
    • Diagnostic centers
    • Neurologic clinics
    • Research institutions
  • Regional Insights (Revenue, USD Bn, 2019 - 2031)
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa
  • Key Players Insights
    • Nihon Kohden Corporation
    • Integra LifeSciences
    • Compumedics Limited
    • BioDirection (NanoDx)
    • Oculogica
    • Abbott Laboratories
    • BrainScope Company Inc.
    • Magstim
    • BIOMÉRIEUX S.A.
    • Advanced Brain Monitoring, Inc.
    • Healius Limited
    • Siemens Healthineers
    • GE Healthcare
    • Philips Healthcare
    • Medtronic plc

Share

About Author

Vipul Patil is a dynamic management consultant with 6 years of dedicated experience in the pharmaceutical industry. Known for his analytical acumen and strategic insight, Vipul has successfully partnered with pharmaceutical companies to enhance operational efficiency, cross broader expansion, and navigate the complexities of distribution in markets with high revenue potential.

Missing comfort of reading report in your local language? Find your preferred language :

Frequently Asked Questions

The global concussion market is estimated to be valued at USD 6.82 Bn in 2024 and is expected to reach USD 10.20 Bn by 2031.

The CAGR of the global concussion market is projected to be 5.9% from 2024 to 2031.

Increasing awareness about concussion management in sports and healthcare sectors and rising incidence of sports-related injuries leading to higher diagnosis rates are the major factors driving the growth of the global concussion market.

Limited availability of advanced diagnostic tools in developing regions and high costs associated with concussion treatment and rehabilitation are the major factors hampering the growth of the global concussion market.

In terms of assessment methods, diagnosis is estimated to dominate the market revenue share in 2024.

Nihon Kohden Corporation, Integra LifeSciences, Compumedics Limited, BioDirection (NanoDx), Oculogica, Abbott Laboratories, BrainScope Company Inc., Magstim, BIOMÉRIEUX S.A., Advanced Brain Monitoring, Inc., Healius Limited, Siemens Healthineers, GE Healthcare, Philips Healthcare, and Medtronic plc are the major players.

North America is expected to lead the global concussion market in 2024.
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Select a License Type





Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.